Projects funded by the NCN
Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile
2021/43/B/NZ7/01732
Keywords:
central nervous system diseases neurodegenerative diseases computer-assisted drug design caspases kinases multi-target drugs G protein-coupled receptors
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 11
Call: OPUS 22 - announced on 2021-09-15
Amount awarded: 1 944 680 PLN
Project start date (Y-m-d): 2022-08-01
Project end date (Y-m-d): 2025-07-31
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.